{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:52:02Z","timestamp":1780631522738,"version":"3.54.1"},"reference-count":49,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacy"],"abstract":"<jats:p>Adherence and persistence to specialty medications are necessary to achieve successful outcomes of costly therapies. The increasing use of specialty medications has exposed several unique barriers to certain specialty treatments\u2019 continuation. Integrated specialty pharmacy teams facilitate transitions in sites of care, between different provider types, among prescribed specialty medications, and during financial coverage changes. We review obstacles encountered within these types of transitions and the role of the specialty pharmacist in overcoming these obstacles. Case examples for each type of specialty transition provide insight into the unique complexities faced by patients, and shed light on pharmacists\u2019 vital role in patient care. This insightful and real-world experience is needed to facilitate best practices in specialty care, particularly in the growing number of health-system specialty pharmacies.<\/jats:p>","DOI":"10.3390\/pharmacy7040163","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T04:30:35Z","timestamp":1575433835000},"page":"163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities"],"prefix":"10.3390","volume":"7","author":[{"given":"Autumn D.","family":"Zuckerman","sequence":"first","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Carver","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Cooper","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Markley","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5300-4617","authenticated-orcid":false,"given":"Victoria W.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marci","family":"Saknini","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houston","family":"Wyatt","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Kelley","sequence":"additional","affiliation":[{"name":"Specialty Pharmacy Services, Vanderbilt University Medical Center, Nashville, TN 37212, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"ref_1","first-page":"542","article-title":"Health plan utilization and costs of specialty drugs within 4 chronic conditions","volume":"19","author":"Gleason","year":"2013","journal-title":"J. Manag. Care Pharm."},{"key":"ref_2","unstructured":"NASP (2019, November 15). NASP Definitions of Specialty Pharmacy and Specialty Medications. Available online: http:\/\/naspnet.org\/wp-content\/uploads\/2017\/02\/NASP-Defintions-final-2.16.pdf."},{"key":"ref_3","unstructured":"AMCP (2016). The AMCP Format for Formulary Submissions, AMCP."},{"key":"ref_4","unstructured":"U.S. Food and Drug Administration (2019). 2018 New Drug Therapy Approvals."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1377\/hlthaff.2014.0558","article-title":"The impact of specialty pharmaceuticals as drivers of health care costs","volume":"33","author":"Hirsch","year":"2014","journal-title":"Health Aff."},{"key":"ref_6","first-page":"20","article-title":"How Employers Are Looking at Specialty Pharmacy Today","volume":"33","author":"Morris","year":"2017","journal-title":"Benefits Q."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/jama.2018.5367","article-title":"Value-Based Pricing and Patient Access for Specialty Drugs","volume":"319","author":"Robinson","year":"2018","journal-title":"JAMA"},{"key":"ref_8","unstructured":"Express Scripts (2018). 2018 Drug Trend Report, Express Scripts."},{"key":"ref_9","unstructured":"CVS Health (2018). Trend Report, CVS Health."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2146\/ajhp150181","article-title":"Specialty pharmacy and the medication access dilemma","volume":"72","author":"Hanson","year":"2015","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.japh.2018.09.004","article-title":"Modeling specialty medicine access: Understanding key health system processes and players","volume":"59","author":"Cocohoba","year":"2019","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2146\/ajhp090462","article-title":"Specialty pharmacies and other restricted drug distribution systems: Financial and safety considerations for patients and health-system pharmacists","volume":"66","author":"Kirschenbaum","year":"2009","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2146\/ajhp170319","article-title":"Implementation and quality assessment of a pharmacy services call center for outpatient pharmacies and specialty pharmacy services in an academic health system","volume":"75","author":"Rim","year":"2018","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_14","first-page":"815","article-title":"Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System","volume":"23","author":"Bagwell","year":"2017","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2146\/ajhp140796","article-title":"Importance of specialty pharmacy to your health system","volume":"72","author":"Colgan","year":"2015","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2146\/ajhp150805","article-title":"Benefits of developing a collaborative, outcomes-based specialty pharmacy program","volume":"73","author":"Pulvermacher","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2146\/ajhp130495","article-title":"Integrated clinical and specialty pharmacy practice model for management of patients with Multiple Sclerosis","volume":"71","author":"Hanson","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_18","unstructured":"Lussier, M.E., Evans, H.J., Wright, E.A., and Gionfriddo, M.R. (2019). The impact of community pharmacist involvement on transitions of care: A systematic review and meta-analysis. J. Am. Pharm. Assoc., 1544\u20133191."},{"key":"ref_19","unstructured":"Bethishou, L., Herzik, K., Fang, N., Abdo, C., and Tomaszewski, D.M. (2019). The impact of the pharmacist on continuity of care during transitions of care: A systematic review. J. Am. Pharm. Assoc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.sapharm.2017.10.007","article-title":"Characteristics of patients using specialty medications","volume":"14","author":"Park","year":"2018","journal-title":"Res. Social Adm. Pharm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2017.08.042","article-title":"The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease","volume":"191","author":"Barnes","year":"2017","journal-title":"J. Pediatrics"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Shah, N.B., Mitchell, R.E., Proctor, S.T., Choi, L., DeClercq, J., Jolly, J.A., Hemnes, A.R., and Zuckerman, A.D. (2019). High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217798"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/07853890.2018.1461919","article-title":"Adult hospital admissions associated with multiple sclerosis in Finland in 2004\u20132014","volume":"50","author":"Pirttisalo","year":"2018","journal-title":"Ann. Med."},{"key":"ref_24","unstructured":"Hertzka, R.E. (2016). Medication \u201cBrown Bagging\u201d, Resolution 827-I-15."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1053\/j.gastro.2016.08.004","article-title":"Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response","volume":"151","author":"Terrault","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1503\/cmaj.050176","article-title":"\u201cAvoid the crush\u201d: Hazards of medication administration in patients with dysphagia or a feeding tube","volume":"172","author":"Cornish","year":"2005","journal-title":"CMAJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.xphs.2018.02.015","article-title":"A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir\/Pibrentasvir Tablets on Exposures in Healthy Subjects","volume":"107","author":"Oberoi","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11606-018-4695-0","article-title":"Lost in Transition: A Qualitative Study of Patients Discharged from Hospital to Skilled Nursing Facility","volume":"34","author":"Gadbois","year":"2019","journal-title":"J. Gen. Intern. Med."},{"key":"ref_29","first-page":"177","article-title":"Health Care Systems and Transitions of Care: Implication on Interdisciplinary Pharmacy Services","volume":"78","author":"Bush","year":"2017","journal-title":"N. C. Med. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.sapharm.2018.09.003","article-title":"Health care utilization and expenditures among adults with rheumatoid arthritis using specialty pharmaceuticals","volume":"15","author":"Park","year":"2018","journal-title":"Res. Soc. Adm. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1377\/hlthaff.20.6.146","article-title":"Changing the chronic care system to meet people\u2019s needs","volume":"20","author":"Anderson","year":"2001","journal-title":"Health Aff."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/01.mlr.0000182530.52979.29","article-title":"Primary care attributes, health care system hassles, and chronic illness","volume":"43","author":"Parchman","year":"2005","journal-title":"Med. Care"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jacl.2019.01.003","article-title":"Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates","volume":"13","author":"Reynolds","year":"2019","journal-title":"J. Clin. Lipidol."},{"key":"ref_34","first-page":"1394","article-title":"Adherence to Disease-Modifying Therapies at a Multiple Sclerosis Clinic: The Role of the Specialty Pharmacist","volume":"22","author":"Banks","year":"2019","journal-title":"J. Pharm. Pract."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/21556660.2018.1521081","article-title":"Impact of comprehensive pharmacy services on patient centered outcomes in a hematology and oncology clinic","volume":"7","author":"Swisher","year":"2018","journal-title":"J. Drug Assess."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e11168","DOI":"10.2196\/11168","article-title":"The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods Study","volume":"20","author":"Simacek","year":"2018","journal-title":"J. Med. Internet Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1200\/JOP.2016.012302","article-title":"Potential Obstacles in the Acquisition of Oral Anticancer Medications","volume":"13","author":"Niccolai","year":"2017","journal-title":"J. Oncol. Pract."},{"key":"ref_38","unstructured":"National Comprehensive Cancer Network (2019). NCCN Clinical Practice Guidelines in Oncology: Multiple Myeloma, National Comprehensive Cancer Network. version 3.2019."},{"key":"ref_39","unstructured":"Khorana, A.A., Tullio, K., Elson, P., Pennell, N.A., Kalady, M.F., Raymond, D., Klein, E.A., Abraham, J., Grobmyer, S.R., and Monteleone, E.E. (June, January 31). Increase in time to initiating cancer therapy and association with worsened survival in curative settings: A U.S. analysis of common solid tumors. Proceedings of the A merican Society of Clinical Oncology Annual Meeting, Chicago, IL, USA."},{"key":"ref_40","unstructured":"Cassano, A. (2019). ASHP Specialty Pharmacy Resource Guide, ASHP."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2146\/ajhp150749","article-title":"Specialty pharmacy for hematologic malignancies","volume":"73","author":"Fajardo","year":"2016","journal-title":"Am. J. Health Syst. Pharm."},{"key":"ref_42","unstructured":"American Medical Association (2018). 2018 Prior Authorization State Law Chart, American Medical Association."},{"key":"ref_43","unstructured":"Fein, A., Gill, L., and Long, D. (May, January 29). Specialty Pharmacy Industry Outlook: What\u2019s Next?. Proceedings of the Asembia Specialty Pharmacy Summit, Las Vegas, NV, USA."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1001\/jama.2019.4492","article-title":"Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019","volume":"321","author":"Dusetzina","year":"2019","journal-title":"JAMA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/bmj.327.7419.863","article-title":"Perspectives from the pharmaceutical industry","volume":"327","author":"Bonaccorso","year":"2003","journal-title":"BMJ"},{"key":"ref_46","first-page":"1167","article-title":"Impact of Pharmacy Intervention on Prior Authorization Success and Efficiency at a University Medical Center","volume":"22","author":"Cutler","year":"2016","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zuckerman, A., Douglas, A., Nwosu, S., Choi, L., and Chastain, C. (2018). Increasing success and evolving barriers in the hepatitis C cascade of care during the direct acting antiviral era. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0199174"},{"key":"ref_48","unstructured":"Marden, B., and Martineau, C. (2019, November 15). Emphasize Medication Adherence to Patients. Pharmacy Times. Available online: https:\/\/www.pharmacytimes.com\/publications\/health-system-edition\/2019\/september2019\/emphasize-medication-adherence-to-patients."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-157-11-201212040-00538","article-title":"Interventions to improve adherence to self-administered medications for chronic diseases in the United States: A systematic review","volume":"157","author":"Viswanathan","year":"2012","journal-title":"Ann. Intern. Med."}],"container-title":["Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2226-4787\/7\/4\/163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:39:40Z","timestamp":1760189980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2226-4787\/7\/4\/163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["pharmacy7040163"],"URL":"https:\/\/doi.org\/10.3390\/pharmacy7040163","relation":{},"ISSN":["2226-4787"],"issn-type":[{"value":"2226-4787","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]}}}